The University of Toledo is a public research university in Toledo, Ohio. It is the northernmost campus of the University System of Ohio.

During the past decade, University of Toledo conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 111 clinical trials were completed, i.e. on average, 158.6% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 47 clinical trials were completed. i.e. 204.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Toledo" #1 sponsor was "National Cancer Institute (NCI)" with 62 trials, followed by "SWOG Cancer Research Network" with 19 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "University of Toledo Health Science Campus" with 10 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 10 trials sponsored. Other sponsors include 111 different institutions and companies that sponsored additional 81 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Toledo" #1 collaborator was "National Cancer Institute (NCI)" with 60 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 6 trials as a collaborator. Other collaborators include 68 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "University of Toledo" are "HIV Infections" (10 trials), "Breast Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Parkinson Disease" (8 trials) and "Recurrent Breast Carcinoma" (8 trials). Many other conditions were trialed in "University of Toledo" in a lesser frequency.

Most popular intervention types in "University of Toledo" are "Drug" (178 trials), "Other" (100 trials), "Biological" (59 trials), "Radiation" (21 trials) and "Procedure" (18 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (63 trials), "Quality-of-Life Assessment" (30 trials), "Placebo" (23 trials), "Bevacizumab" (17 trials) and "Paclitaxel" (17 trials). Other intervention names were less common.

The vast majority of trials in "University of Toledo" are 187 trials for "All" genders, 29 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "University of Toledo". undefined are not yet recruiting, 19 are recruiting, 57 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 110 completed trials in University of Toledo, undefined suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in University of Toledo, 9 "Phase 1" clinical trials were conducted, 79 "Phase 2" clinical trials and 116 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 17 trials that are defined as “Not Applicable".

University of Toledo has several departments that took part in Clinical trials: "Medical University of Ohio Cancer Center" - 131 trials, "Medical College of Ohio, Department of Neurology" - 4 trials, "Cardiovascular Research Center" - 3 trials, "University of Toledo, Eleanor N. Dana Cancer Center" - 3 trials